Drawing for DRAQ5

USPTO serial 79229070

DRAQ5

Reviewed by CopyMark Law Group

Reg. 5777978Status 739Registered
Filing date
Status date
Registration date
Jun 18, 2019
Examiner
PODESTA, GIDETTE
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with DRAQ5?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicole M. Meyer

Nicole M. Meyer Dickinson Wright PLLC1825 Eye St. N.W., Suite 900Washington, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic scanning agents for in-vivo use other than for medical use; in-vivo diagnostic scanning agents for scientific use; chemicals for use in industry and science, namely, fluorescent chemicals; chemicals for use in industry and science, namely, fluorescent substances; chemical preparations for use in DNA analysis for other than medical or veterinary use; chemical substances, chemical materials in the nature of reagents and substrates and chemical preparations for cell-based scientific research; chemical reagent mixtures in kit form for testing, other than for medical or veterinary use; chemical reagent mixtures in a kit form for testing, other than for medical or veterinary use; chemical reagent mixtures, other than for medical or veterinary use; chemical reagents for identification of microorganisms, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; chemical reagents for molecular biology, other than for medical or veterinary use; chemical reagents for non-medical purposes; chemical reagents for susceptibility determinations, other than for medical or veterinary use; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; chemical reagents for use in diagnosis, other than for medical or veterinary use; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical reagents for use in industry; chemical reagents for use in science, other than for medical or veterinary use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical substances for analysis in laboratories not for medical or veterinary purposes; chemical substances for use in the biotechnological industry, namely, chemical substances for cell-based research; chemical substances for use in bioluminescent processes for scientific use; chemical substances for use in the biochemical industry, namely, chemical substances for cell-based research; chemical test reagents other than medical or veterinary purposes; chemicals for use as fluorescent substrates; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemicals for use in immuno-assay testing other than medical or veterinary use; chemicals for use in separation other than for medical or veterinary use; chemicals for use in separation techniques other than medical or veterinary use; chemicals for use in the pharmaceutical industry; chemicals for use in the agrochemical industry; chemicals for use in the manufacture of dyestuffs; chemicals having antimicrobial properties for scientific use other than medical or veterinary use; colorimetric chemicals; diagnostic chemicals other than for medical or veterinary use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, other than for medical or veterinary use; diagnostic reagents for in-vitro use other than medical purposes; diagnostic reagents, except for medical or veterinary use; diagnostic reagents for scientific purposes, other than for medical laboratory use; diagnostic reagents, other than for medical use for sale in kit form; diagnostic scanning agents for in-vivo use other than medical purposes; diagnostic substances, other than for medical use; diagnostic testing materials, other than for medical use being diagnostic preparations for scientific use; fine chemicals for use in industry; fluorescent chemicals for use in cell-based research; fluorescent chemicals for use as a fluorescent label; chemicals used in industry, namely, fluorescent labels for nucleotides and proteins; fluorescent substances, namely, fluorescent dye for scientific or research use; reagents for analytical purposes other than for medical or veterinary purposes; reagents for bacteriological analysis of culture water other than for medical or veterinary purposes; reagents for scientific use, namely, reagents for chemical analyses; reagents for scientific use, namely, reagent for chemical analyses; reagents for in-vitro laboratory use other than for medical or veterinary purposes; reagents for industrial purposes; reagents for laboratory purposes other than for medical or veterinary purposes; reagents for medical research; reagents for microbiological analysis other than for medical or veterinary purposes; reagents for research purposes; reagents for scientific or medical research use; reagents for testing aqueous solutions other than for medical or veterinary purposes; reagents for testing water; reagents for testing the sterility of medical equipment; reagents for research purposes, namely, reagents for testing the sterility of pharmaceuticals and injectable solutions; reagents for use in analytical tests other than for medical or veterinary purposes; reagents for use in analysis other than for medical or veterinary purposes; reagents for use in biological processing other than for medical or veterinary purposes; reagents for use in diagnostic tests other than for medical or veterinary purposes; reagents for use in environmental analysis; reagents for use in environmental testing; reagents for use in medical research, namely, reagents for use in immunoserology research; reagents for use in scientific apparatus for chemical or biological analysis; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; reagents for use in the development of monoclonal antibodies other than for medical or veterinary purposes; reagents for use with analyzers other than for medical or veterinary purposes; reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) other than for medical or veterinary purposes; test reagents other than for medical use; testing reagents for industrial use; water testing chemicalsACTIVE—
005Medical and veterinary preparations and articles, namely, biological preparations for use as diagnostic agents; diagnostic preparations for medical purposes; chemical preparations for testing blood for medical purposes; chemical preparations for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical use; chemical reagents for veterinary use; chemical test reagents for medical use; chemical test reagents for veterinary use; clinical diagnostic reagents; clinical medical reagents; diagnostic reagents for medical use; diagnostic substances for medical use, namely, diagnostic reagent for medical and diagnostic purposes; diagnostic testing materials for medical use; immunoassay reagents for medical use; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for medical use; diagnostic agents for medical purposes, namely, diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for analytical purposes for medical purposes; reagents for analytical purposes for veterinary purposes; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in analysis for medical purposes reagents for use in analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; veterinary diagnostic reagentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 14, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 14, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Apr 14, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 21, 2024ES75TEAS SECTION 71 & 15 RECEIVED—
Oct 18, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 27, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 26, 2019FIMPFINAL DISPOSITION PROCESSED—
Sep 18, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 18, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 29, 2019GPNXNOTIFICATION PROCESSED BY IB—
Mar 13, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 13, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 13, 2019NPUBNOTICE OF PUBLICATION—
Feb 27, 2019CNEAEXAMINERS AMENDMENT MAILED—
Feb 27, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 27, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 26, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 13, 2018CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 10, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2018ALIEASSIGNED TO LIE—
Oct 8, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 27, 2018RFNTREFUSAL PROCESSED BY IB—
Apr 11, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 11, 2018RFRRREFUSAL PROCESSED BY MPU—
Apr 6, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 5, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 31, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 27, 2018DOCKASSIGNED TO EXAMINER—
Mar 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 22, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance